These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27235294)
1. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings. Kaufmann FN; Gazal M; Bastos CR; Kaster MP; Ghisleni G Eur J Pharmacol; 2016 Aug; 784():192-8. PubMed ID: 27235294 [TBL] [Abstract][Full Text] [Related]
2. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. Lopresti AL J Psychopharmacol; 2017 Mar; 31(3):287-302. PubMed ID: 28135888 [TBL] [Abstract][Full Text] [Related]
3. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats. Zhang L; Luo J; Zhang M; Yao W; Ma X; Yu SY Int J Neuropsychopharmacol; 2014 May; 17(5):793-806. PubMed ID: 24405689 [TBL] [Abstract][Full Text] [Related]
4. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. Lopresti AL; Hood SD; Drummond PD J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of curcumin on sepsis and mechanisms of action: A systematic review of preclinical studies. Karimi A; Ghodsi R; Kooshki F; Karimi M; Asghariazar V; Tarighat-Esfanjani A Phytother Res; 2019 Nov; 33(11):2798-2820. PubMed ID: 31429161 [TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases. Momtazi AA; Derosa G; Maffioli P; Banach M; Sahebkar A Mol Diagn Ther; 2016 Aug; 20(4):335-45. PubMed ID: 27241179 [TBL] [Abstract][Full Text] [Related]
7. Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. Tizabi Y; Hurley LL; Qualls Z; Akinfiresoye L Molecules; 2014 Dec; 19(12):20864-79. PubMed ID: 25514226 [TBL] [Abstract][Full Text] [Related]
9. Cellular and Molecular Mechanisms of Curcumin in Thyroid Gland Disorders. Shakeri F; Bibak B; Safdari MR; Keshavarzi Z; Jamialahmadi T; Sathyapalan T; Sahebkar A Curr Med Chem; 2022; 29(16):2878-2890. PubMed ID: 35142266 [TBL] [Abstract][Full Text] [Related]
10. Curcumin as a potential therapeutic agent for treating neurodegenerative diseases. Perales-Salinas V; Purushotham SS; Buskila Y Neurochem Int; 2024 Sep; 178():105790. PubMed ID: 38852825 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease. Abdul-Rahman T; Awuah WA; Mikhailova T; Kalmanovich J; Mehta A; Ng JC; Coghlan MA; Zivcevska M; Tedeschi AJ; de Oliveira EC; Kumar A; Cantu-Herrera E; Lyndin M; Sikora K; Alexiou A; Bilgrami AL; Al-Ghamdi KM; Perveen A; Papadakis M; Ashraf GM Biofactors; 2024; 50(4):693-708. PubMed ID: 38226733 [TBL] [Abstract][Full Text] [Related]
12. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin. Huang Y; Cao S; Zhang Q; Zhang H; Fan Y; Qiu F; Kang N Arch Biochem Biophys; 2018 May; 646():31-37. PubMed ID: 29596797 [TBL] [Abstract][Full Text] [Related]
13. Curcumin as a potential protective compound against cardiac diseases. Jiang S; Han J; Li T; Xin Z; Ma Z; Di W; Hu W; Gong B; Di S; Wang D; Yang Y Pharmacol Res; 2017 May; 119():373-383. PubMed ID: 28274852 [TBL] [Abstract][Full Text] [Related]
14. Curcumin and nano-curcumin applications in psychiatric disorders. Mohammadzadeh R; Fathi M; Pourseif MM; Omidi Y; Farhang S; Barzegar Jalali M; Valizadeh H; Nakhlband A; Adibkia K Phytother Res; 2024 Aug; 38(8):4240-4260. PubMed ID: 38965868 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment with curcumin attenuates anxiety while strengthens memory performance after one short stress experience in male rats. Haider S; Naqvi F; Batool Z; Tabassum S; Sadir S; Liaquat L; Naqvi F; Zuberi NA; Shakeel H; Perveen T Brain Res Bull; 2015 Jun; 115():1-8. PubMed ID: 25869755 [TBL] [Abstract][Full Text] [Related]
16. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges. Zhang Y; Li L; Zhang J Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):243-253. PubMed ID: 32544307 [TBL] [Abstract][Full Text] [Related]
18. Curcumin in epilepsy disorders. Dhir A Phytother Res; 2018 Oct; 32(10):1865-1875. PubMed ID: 29917276 [TBL] [Abstract][Full Text] [Related]
19. Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats. Ciftci O; Turkmen NB; Taslıdere A Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):783-791. PubMed ID: 29721577 [TBL] [Abstract][Full Text] [Related]
20. Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways. Joshi P; Bisht A; Joshi S; Semwal D; Nema NK; Dwivedi J; Sharma S Phytother Res; 2022 Aug; 36(8):3143-3180. PubMed ID: 35790042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]